MedTrace Logo

Modafinil in Treating Fatigue in Patients With Cancer

NCT00112515 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2009-08-20

No results posted yet for this study

Summary

RATIONALE: Modafinil may help relieve fatigue and improve quality of life in patients with cancer.

PURPOSE: This clinical trial is studying how well modafinil works in treating fatigue in patients with cancer.

Conditions

  • Cognitive/Functional Effects
  • Depression
  • Fatigue
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

modafinil

PROCEDURE

cognitive assessment

PROCEDURE

psychosocial assessment and care

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Virginia

    lead OTHER

Principal Investigators

  • Leslie Blackhall, MD · University of Virginia

Study Design

Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00112515 on ClinicalTrials.gov